Recombinant human growth hormone (Junhemeng Biopharmaceutical)

重组人生长激素（君合盟）

Report date: 2026/02/10 20:00:22

Base Information

Drug NameRecombinant human growth hormone (Junhemeng Biopharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJunhemeng Biopharmaceutical (Hangzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJunhemeng Biopharmaceutical (Hangzhou) Co Ltd
Active IndicationsGrowth Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A